Machine learning sharpens CAD prediction but falls short in detecting plaques most likely to cause cardiac events in patients ...

Percutaneous cryoablation yields outcomes comparable to robotic surgery for renal cancer, at significantly lower cost, Danish ...

EUSEM president Dr Robert Leach discusses the state of emergency medicine, beacons of hope and plans for navigating difficult ...

The success and recent expansion of a pioneering AF virtual ward project in Leicester could prevent thousands of hospital ...

Dr William Tillett highlights missed opportunities for early intervention in psoriatic arthritis and action for clinicians to ...

Professor Lindsay J Hall explains how introducing probiotics into neonatal care can help combat antimicrobial resistance in ...

A modelling tool can estimate the longevity of a variety of CIEDs, allowing clinicians to choose the most appropriate device ...

Moving medical supplies via drone was once a farfetched idea, but there are now multiple projects working to make it a reality. Kathy Oxtoby considers five case studies from the UK and the Netherlands ...

The role of beta-blockers after myocardial infarction (MI) in patients with mildly reduced left ventricular ejection fraction (LVEF) is under debate, after new research was unveiled at the European ...

The investigational, highly selective aldosterone synthase inhibitor baxdrostat has shown significant reductions in blood pressure compared with placebo at 12 weeks in patients with uncontrolled or ...

A new study highlights the risks of atopic dermatitis flare-ups after discontinuing the use of dupilumab. Nearly half of patients who stopped taking the systemic biologic treatment, for reasons other ...

The cystic fibrosis (CF) medication ivacaftor (brand name Kalydeco) is safe and effective in infants aged four weeks and over, paving the way for earlier initiation of therapy for newborns diagnosed ...